Mpi Stannous Diphosphonate

NDA 17667, held by Ge Healthcare. Technetium Tc-99m Etidronate Kit.

As of Nov 14, 2026, NDA 17667 (Mpi Stannous Diphosphonate), held by Ge Healthcare, was first approved by FDA on Apr 1, 1977, with 2 approved supplements and 0 published complete response letters.

First approved: Apr 1, 1977
Review: Standard
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Apr 1, 1977	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Mpi Stannous DiphosphonateN/A · injectable;injection	Technetium Tc-99m Etidronate Kit	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Sep 17, 2001	Supplement 4Labeling	Approved	None posted
Aug 3, 1979	Supplement 3Labeling	Approved	None posted
Apr 1, 1977	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Identifiers

Application: NDA 17667
Drugs@FDA: Overview at FDA
Company: GE Healthcare

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters